医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
((5-噻唑基)甲基)-(4-硝基苯基)碳酸酯 | 4-nitrophenyl (thiazol-5-ylmethyl) carbonate | 144163-97-3 | C11H8N2O5S |
|
((4-羟基丁基)氮杂二基)双(己烷-6,1-二基)双(2-己基癸酸酯) | ALC-0315 | 2036272-55-4 | C48H95NO5 |
|
((3aR,4S,6aS)-5-乙酰氧基-2-氧代六氢-2H-环戊并[b]呋喃-4-基)甲基 乙酸酯 | ((3aR,4S,5R,6aS)-5-acetoxy-2-oxohexahydro-2H-cyclopenta[b]furan-4-yl)methyl acetate | 62939-82-6 | C12H16O6 |
|
((3R,4S)-3-氟哌啶-4-基)氨基甲酸叔丁酯 | tert-butyl N-[(3R,4S)-3-fluoropiperidin-4-yl]carbamate | 1630815-57-4 | C10H19FN2O2 |
|
((3R,4R)-4-氨基四氢-2H-吡喃-3-基)氨基甲酸叔丁酯 | tert-butyl ((3R,4R)-4-aminotetrahydro-2H-pyran-3-yl)carbamate | 1240390-36-6 | C10H20N2O3 |
|
((3AR,4R,6R,6AR)-6-(4-(羟氨)-2-恶嘧啶-1(2H)-甲基)-2,2-二甲基四氢呋喃[3,4-D][1,3]二氧醇-4-基)异丁酸甲酯 | molnupiravir acetonide | 2346620-55-9 | C16H23N3O7 |
|
((2S)-2-氨基丙基)氨基甲酸叔丁酯 | tert-butyl (S)-(2-aminopropyl)carbamate | 121103-15-9 | C8H18N2O2 |
|
((2R,3r,4r)-3-((4-氯苯甲酰基)氧基)-4-氟-4-甲基-5-氧代四氢呋喃-2-基)甲基4-氯苯甲酸 | ((2R,3R,4R) 3-(4-chlorobenzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl-4-chlorobenzoate | 1294481-79-0 | C20H15Cl2FO6 |
|
((2R,3R,4R)-3-(苯甲酰氧基)-4-氟-4-甲基-5-氧代四氢呋喃-2-基)苯甲酸甲酯 | ((2R,3R,4R)-3-benzoyloxy-4-fluoro-4-methyl-5-oxo-tetrahydrofuran-2-yl)methyl benzoate | 874638-80-9 | C20H17FO6 |
|
((1R,3R,4R)-3-羟基-4-甲基环己基)氨基甲酸叔丁酯 | tert-butyl ((1R,3R,4R)-3-hydroxy-4-methylcyclohexyl)carbamate | 1403864-94-7 | C12H23NO3 |
|
((1R,2S)-2-氨基环己基)氨基甲酸叔丁酯 | tert-butyl ((1R,2S)-2-aminocyclohexyl)carbamate | 364385-54-6 | C11H22N2O2 |
|
((1R,2R)-2-羟基-1-羟甲基-2-苯基乙基)氨基甲酸叔丁酯 | ((1R,2R)-2-hydroxy-1-hydroxymethyl-2-phenylethyl)carbamic acid tert-butyl ester | 1009093-14-4 | C14H21NO4 |
|
—— | 2-Benzyloctahydro-1H-pyrrolo[3,4-c]pyridine hydrochloride | 1187927-49-6 | C14H21ClN2 |
|
—— | 6-cyanopyridin-2-ylboronic acid | 848500-38-9 | C6H5BN2O2 |
|
—— | 3-O-β-Glucosyl-platycodigenin | 38337-25-6 | C36H58O12 |
|
—— | (3-bromophenyl)dimethylphosphine oxide | 60398-84-7 | C8H10BrOP |
|
—— | 1-((trans)-4-methylcyclohexyl)ethanone | 18446-90-7 | C9H16O |
|
—— | (1S,5R)-5-Benzyloxymethyl-cyclopent-2-enol | 668996-19-8 | C13H16O2 |
|
—— | trans-4-(Methylamino)cyclohexanol hydrochloride | 923023-08-9 | C7H15NO*ClH |
|
—— | 3,3-difluoro-2,2-dimethylpropanoic acid | 1022154-50-2 | C5H8F2O2 |
|
—— | tert-butyl-4-(methacryloyloxy)piperidine-1-carboxylate salt | 1229727-38-1 | C14H23NO4 |
|
—— | 2-Ethynyl-6-(trifluoromethyl)pyrazine | 1211529-10-0 | C7H3F3N2 |
|
—— | 4-chloro-N-((R)-1-((1s,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)ethyl)benzamide | 1923844-48-7 | C24H24ClFN2O |
|
—— | N-(4-((6-azidohexyloxy)diphenylsilyloxy)butyl)-1-(5-((3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl)-pentanamido)-3,6,9,12-tetraoxapentadecan-15-amide | 1260247-50-4 | C43H67N7O9SSi |
|
—— | 73428-45-2 | C6H7N2O2 |
|
|
—— | 1404074-90-3 | C2F3O2*C7H13N2 |
|
|
—— | 4-Pyridinol, 3,5-dibromo-, ion(1-) | 141375-47-5 | C5H2Br2NO |
|
—— | 3-(3,5-dichloro-4-methoxybenzoyl)-1-oxo-2,3-dihydro-1,3-benzothiazole | 1285573-47-8 | C15H11Cl2NO3S |
|
—— | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]indole-3-carbaldehyde | 460355-03-7 | C14H15NO4 |
|
—— | 3-bromobenzofuran-2-carbonitrile | 1357347-11-5 | C9H4BrNO |
|
—— | 7'-fluoro-1',2'-dihydrospiro[cyclopropane -1,3-indole]-2'-one | 872141-30-5 | C10H8FNO |
|
—— | 5-(bromomethyl)-2,3-dimethylpyrazine | 1339947-51-1 | C7H9BrN2 |
|
—— | 4-methoxy-1-piperidin-4-ylpiperidine hydrochloride | 930604-26-5 | C11H22N2O*ClH |
|
—— | bis(4-bromophenyl)phosphine oxide | 15754-53-7 | C12H9Br2OP |
|
—— | 5-(2-chloroacetamido)-2,4,6-triiodo-N,N'-bis(2,3-bis(2-chloroacetoxy)propyl)isophthalamide | 155887-14-2 | C24H23Cl5I3N3O11 |
|
—— | Pubchem_57369830 | 70431-34-4 | C11H21NNa3O7+3 |
|
—— | sulfopin | 2451481-08-4 | C11H20ClNO3S |
|
—— | ethyl 4-bromo-5-methyl-1H-imidazole-2-carboxylate | 1171125-20-4 | C7H9BrN2O2 |
|
—— | 17-Alpha-cyano-9-alpha,17-beta-dihydroxyandrost-4-en-3-one | 116256-35-0 | C20H27NO3 |
|
—— | 2-[(2R,3R)-2-Methanesulfinyl-4-oxo-3-(2-phenoxy-acetylamino)-azetidin-1-yl]-3-methyl-but-2-enoic acid 4-methoxy-benzyl ester | 36760-29-9 | C25H28N2O7S |
|
—— | Benzo[f]furo[3,2-c]quinoline | 195-66-4 | C15H9NO |
|
—— | benzyl (S)-2-(((3-chloropyrazin-2-yl)methyl)carbamoyl)pyrrolidine-1-carboxylate (benzyl (S)-2-(((3-chloropyrazin-2-yl)methyl)carbamoyl)pyrrolidine-1-carboxylate) | 2251014-87-4 | C18H19ClN4O3 |
|
—— | D-Lysergic acid methyl ester | 4579-64-0 | C17H18N2O2 |
|
—— | 3,3,5-trifluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | 1452561-47-5 | C7H3F3N2O |
|
—— | Quinoline sulfate | 530-66-5 (bisulfate) | C18H16N2O4S |
|
—— | 1,6-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid | 934106-78-2 | C9H9N3O2 |
|
—— | 7-bromo-5-fluoro-1H-pyrrolo[2,3-c]pyridine | 1639977-12-0 | C7H4BrFN2 |
|
—— | Gpl23NZ2Q9 | 2061897-68-3 | C34H38N4O5 |
|
—— | trans-Octahydro-1H-pyrrolo[3,4-b]pyridine | 158060-81-2 | C7H14N2 |
|
—— | Ethyl-1-methyl-3-hydroxypyrrol-2-carboxylat | 65171-90-6 | C8H11NO3 |
|